Australia markets closed

Heron Therapeutics, Inc. (HRTX)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
3.0500-0.0500 (-1.61%)
At close: 04:00PM EDT
3.0600 +0.01 (+0.33%)
After hours: 06:48PM EDT
Show:
Income statement
Cash flow
Annual

Balance sheet

All numbers in thousands
Breakdown
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Assets
Current assets
Cash
Cash and cash equivalents
28,677
15,364
90,541
105,138
-
Other short-term investments
51,732
69,488
67,039
103,353
-
Total cash
80,409
84,852
157,580
208,491
-
Net receivables
60,137
52,049
35,499
41,850
-
Inventory
42,110
54,573
48,382
41,905
-
Other current assets
6,118
13,961
12,962
21,950
-
Total current assets
188,774
205,435
254,423
314,196
-
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
42,632
44,098
46,806
49,886
-
Accumulated depreciation
-17,028
-14,293
-13,243
-10,872
-
Net property, plant and equipment
25,604
29,805
33,563
39,014
-
Other long-term assets
8,128
15,711
17,720
346
-
Total non-current assets
33,732
45,516
51,283
39,360
-
Total assets
222,506
250,951
305,706
353,556
-
Liabilities and stockholders' equity
Liabilities
Current liabilities
Current debt
-
-
-
7,053
5,624
Accounts payable
3,799
3,588
3,873
629
-
Accrued liabilities
64,958
64,791
51,289
79,918
-
Total current liabilities
79,685
82,355
71,058
102,503
-
Non-current liabilities
Long-term debt
173,753
149,284
149,082
-
-
Other long-term liabilities
241
241
-
-
-
Total non-current liabilities
176,794
155,024
157,078
14,561
-
Total liabilities
256,479
237,379
228,136
117,064
-
Stockholders' equity
Common stock
1,503
1,191
1,020
913
-
Retained earnings
-1,906,014
-1,795,455
-1,613,431
-1,392,748
-
Accumulated other comprehensive income
13
-19
-6
257
-
Total stockholders' equity
-33,973
13,572
77,570
236,492
-
Total liabilities and stockholders' equity
222,506
250,951
305,706
353,556
-